Status:
UNKNOWN
Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Seminomas
Eligibility:
MALE
18+ years
Brief Summary
Recent data suggest that sperm cells carry an epigenetic message during spermatogenesis and that this message is crucial for the future development of the embryo. This epigenetic signature is notably ...
Eligibility Criteria
Inclusion
- biological samples from persons who have provided written consent
- biological samples of patients over 18 years old
- with testicular tumours/Fertile/Infertile
- Matched for age with patients suffering from testicular tumours
Exclusion
- biological samples of persons without national health insurance cover
- biological samples from patients with chronic hepatitis B or C or HIV infection
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03262207
Start Date
September 1 2016
End Date
September 1 2017
Last Update
August 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Dijon Bourgogne
Dijon, France, 21079